Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABSI Absci Corporation.

Not Yet Opened 11-12 16:00:00 EST

9.14

-0.98

-9.73%

盘后9.41

+0.28+3.01%

19:55 EST

High9.94	Low8.96	Vol4.92M
Open9.39	D1 Closing10.12	Amplitude9.68%
Mkt Cap1.57B	Tradable Cap1.47B	Total Shares171.61M
T/O46.61M	T/O Rate3.05%	Tradable Shares161.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABSI","market":"US","secType":"STK","nameCN":"Absci Corporation.","latestPrice":9.135,"timestamp":1794517200000,"preClose":10.12,"halted":0,"volume":4918283,"hourTrading":{"tag":"盘后","latestPrice":9.41,"preClose":9.135,"latestTime":"19:55 EST","volume":14388,"amount":134313.0411,"timestamp":1794531341103,"change":0.275,"changeRate":0.030104,"amplitude":0.041051},"delay":0,"changeRate":-0.09733201581027663,"floatShares":161244738,"shares":171614010,"eps":-0.799886,"marketStatus":"Not Yet Opened","change":-0.985,"latestTime":"11-12 16:00:00 EST","open":9.39,"high":9.94,"low":8.96,"amount":46611020.473036006,"amplitude":0.096838,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.799886,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794560400000},"marketStatusCode":0,"adr":0,"listingDate":1626926400000,"exchange":"NASDAQ","adjPreClose":10.12,"preHourTrading":{"tag":"盘前","latestPrice":9.47,"preClose":10.12,"latestTime":"09:29 EST","volume":50078,"amount":474046.761104,"timestamp":1794493799999,"change":-0.65,"changeRate":-0.064229,"amplitude":0.103765},"postHourTrading":{"tag":"盘后","latestPrice":9.41,"preClose":9.135,"latestTime":"19:55 EST","volume":14388,"amount":134313.0411,"timestamp":1794531341103,"change":0.275,"changeRate":0.030104,"amplitude":0.041051},"volumeRatio":1.091968,"impliedVol":1.9612,"impliedVolPercentile":0.948},"requestUrl":"/m/hq/s/ABSI/","defaultTab":"news","newsList":[{"id":"2682359002","title":"Absci Corp Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2682359002","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682359002?lang=en_us&edition=fundamental","pubTime":"2026-11-12 23:06","pubTimestamp":1794496017,"startTime":"0","endTime":"0","summary":"Absci Corp reports results for the quarter ended September 30 - Earnings SummaryAbsci CorpABSI.OQreported a quarterly adjusted loss of 19 cents per share for the quarter ended September 30, higher tha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL5N46T203:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4539","ARKG","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682592688","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Nvidia Leadership Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2682592688","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682592688?lang=en_us&edition=fundamental","pubTime":"2026-11-12 22:08","pubTimestamp":1794492526,"startTime":"0","endTime":"0","summary":" The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.7% and the actively traded Invesco QQQ Trust (QQQ) was 1.3% lower in Thursday's premarket activity as concerns about...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BITO","EQR","USO","VIS","IYE","XSD","SAN","SLV","IBB","NVDA","FAS","VHT","ERX","BETH","SOXX","XLF","XOM","SPY","XLI",".DJI","DPC","XLV","XLY","RTH","QQQ","VDE","IYH","XLE","EETH","FDN","GLD","KDP","XLP","IYJ","RTH.AU","ABSI","UNG","VDC","XRT","STT","IGM","VHT.AU",".IXIC","IYW","SAN.AU","XLK","CRWV","SPY.AU","FAZ","IYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682059450","title":"Absci Corp Files for Mixed Shelf; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2682059450","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682059450?lang=en_us&edition=fundamental","pubTime":"2026-11-12 21:46","pubTimestamp":1794491217,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nFWN46T1I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","BK4139","BK4121","ABSI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682262595","title":"Absci Q3 Loss Narrows, Revenue Falls; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2682262595","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682262595?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:38","pubTimestamp":1794487131,"startTime":"0","endTime":"0","summary":"Absci  reported a Q3 net loss Thursday of $0.19 per diluted share, narrowing from a loss of $0.20 a year earlier.Analysts surveyed by FactSet expected a loss of $0.20.Partner program revenue for the quarter ended Sept. 30 was $304,000, compared with $378,000 a year earlier.The company's shares were down 2.7% in premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABSI","BK4539","ARKG","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682595067","title":"Absci Galderma appoints Gerry Muhle as chief commercial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2682595067","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682595067?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:37","pubTimestamp":1794487042,"startTime":"0","endTime":"0","summary":"Absci (ABSI) announced the appointment of Gerry Muhle as chief commercial officer. Muhle will lead Absci’s commercial strategy, bringing experience...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-galderma-appoints-gerry-muhle-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-galderma-appoints-gerry-muhle-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABSI","BK4539","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682595127","title":"Absci Q3 2026 Net Loss Widens 16% Year over Year to $33.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682595127","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682595127?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:36","pubTimestamp":1794486968,"startTime":"0","endTime":"0","summary":"Absci Q3 2026 net loss widens 16% year over year to $33.3 millionAbsci's third-quarter 2026 net loss widened 16% year-over-year to $33.3 million, while revenue fell 20% to $304,000.Cash, cash equivale","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nNDL58T3pt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4588","BCDF","SG9999014021.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014039.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BQXX3D17.EUR","ARKG","IE00BQXX3C00.GBP","BK4539","BK4121","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4139","ABSI","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682595946","title":"Twist Bioscience Q4 Revenue Beats Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2682595946","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682595946?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:34","pubTimestamp":1794486881,"startTime":"0","endTime":"0","summary":"Twist Bioscience Q4 revenue beats analyst expectationsOverviewSynthetic DNA firm's fiscal Q4 revenue beat analyst expectationsCompany reported a Q4 loss per share of $0.32OutlookTwist Bioscience expec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T0NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","BK4139","GNOM","ABCL","IDNA","BK4121","BK4505","BK4588","WDNA","ARKG","BK4539","BK4535","ABSI","BK4585","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682559318","title":"Earnings Flash (ABSI) Absci Posts Q3 Loss $0.19 a Share, vs. FactSet Est of $0.20 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2682559318","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682559318?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:14","pubTimestamp":1794485641,"startTime":"0","endTime":"0","summary":"Earnings Flash (ABSI) Absci Posts Q3 Loss $0.19 a Share, vs. FactSet Est of $0.20 Loss","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682646593","title":"Absci Q3 Revenue Misses Estimates, Net Loss Widens on R&D Spends","url":"https://stock-news.laohu8.com/highlight/detail?id=2682646593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682646593?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:13","pubTimestamp":1794485615,"startTime":"0","endTime":"0","summary":"Absci Q3 revenue misses estimates, net loss widens on R&D spendsOverviewU.S. biopharma company's Q3 revenue fell and missed analyst expectationsNet loss widened in Q3 as R&D expenses rose for internal","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T0M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","ARKG","PEPG","GPCR","BK4121","PALI","BK4539","BK4139","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682593534","title":"Absci Q3 EPS $(0.19) Beats $(0.20) Estimate, Sales $304.000K Miss $727.125K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2682593534","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682593534?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:08","pubTimestamp":1794485310,"startTime":"0","endTime":"0","summary":"Absci (NASDAQ:ABSI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 5 percent increase over losses of $(0.20) per share from the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/63178517/absci-q3-eps-0-19-beats-0-20-estimate-sales-304-000k-miss-727-125k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABSI","ARKG","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598761","title":"Absci Q3 Revenue USD 304 Thousand Vs. IBES Estimate USD 727.1 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598761","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682598761?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:06","pubTimestamp":1794485160,"startTime":"0","endTime":"0","summary":"BRIEF-Absci Q3 Revenue USD 304 Thousand Vs. IBES Estimate USD 727.1 ThousandNov 12 (Reuters) - Absci Q3 operating expenses USD 35.298 million.Q3 basic EPS USD -0.19Q3 operating income USD -34.994 millionQ3 net income USD -33.3 millionQ3 pretax profit USD -33.282 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","ABSI","BK4139","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682982625","title":"Absci Q3 Net Income USD -33.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682982625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682982625?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:05","pubTimestamp":1794485100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABSI","ARKG","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682759806","title":"Absci Corp - Expects Cash and Securities to Fund Operations into Second Half of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2682759806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682759806?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:05","pubTimestamp":1794485100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ABSI","BK4539","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598285","title":"Absci Q3 Pretax Profit USD -33.282 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682598285?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:05","pubTimestamp":1794485100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4539","ARKG","BK4139","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598256","title":"Absci Q3 Operating Expenses USD 35.298 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598256","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682598256?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:05","pubTimestamp":1794485100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ARKG","BK4539","ABSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598232","title":"Absci Q3 Basic EPS USD -0.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598232","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682598232?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:05","pubTimestamp":1794485100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nPLXJL8XHW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4121","BK4539","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598346","title":"Absci Appoints Gerry Muhle as Chief Commercial Officer to Build Category-Defining Brands for Abs-201 and Its Broader Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682598346?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:00","pubTimestamp":1794484801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nTUA2VKM1J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4121","BK4539","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682741598","title":"Press Release: Absci Appoints Gerry Muhle as Chief Commercial Officer to Build Category-Defining Brands for ABS-201 and Its Broader Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2682741598","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682741598?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:00","pubTimestamp":1794484800,"startTime":"0","endTime":"0","summary":"VANCOUVER, Wash. and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","03160","BK4099","BK4588","R","BK4585","BK4022","BK4121","BK4139","BK4604","BGSX","BK4555","ARKG","BK4539","ABSI","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681064842","title":"Absci (ABSI) On AI Drug Pipeline Debate While Rich Valuation Stays In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2681064842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681064842?lang=en_us&edition=fundamental","pubTime":"2026-11-08 16:30","pubTimestamp":1794126606,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 8, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-on-ai-drug-pipeline-debate-while-rich-valuation-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-on-ai-drug-pipeline-debate-while-rich-valuation-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIX","VTHR","ARKG","CHAT","BK4121","ABSI","BK4539","ARTY","BK4139","QTOC","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100508429","title":"Earning Preview: Absci Corporation. this quarter’s revenue is expected to decrease by 55.76%, and institutional views are cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1100508429","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100508429?lang=en_us&edition=fundamental","pubTime":"2026-11-05 10:48","pubTimestamp":1793846921,"startTime":"0","endTime":"0","summary":"Abstract Absci Corporation. will report quarterly results on November 12, 2026 Pre-MKt; this preview summarizes last quarter’s performance, consensus forecasts for revenue, profitability, and EPS,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Absci Corporation. this quarter’s revenue is expected to decrease by 55.76%, and institutional views are cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.absci.com;investors.absci.com","stockEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":0.0038},{"period":"3month","weight":-0.0049},{"period":"6month","weight":0.7807},{"period":"1year","weight":1.6868},{"period":"ytd","weight":1.6175}],"compareEarnings":[{"period":"1week","weight":0.0329},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0248},{"period":"6month","weight":0.0243},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.1103}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106318},{"month":2,"riseRate":0.6,"avgChangeRate":0.064917},{"month":3,"riseRate":0.4,"avgChangeRate":-0.085447},{"month":4,"riseRate":0.4,"avgChangeRate":0.03426},{"month":5,"riseRate":0.4,"avgChangeRate":0.033031},{"month":6,"riseRate":0.2,"avgChangeRate":0.025606},{"month":7,"riseRate":0.6,"avgChangeRate":0.127868},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.082694},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.063832},{"month":10,"riseRate":0.833333,"avgChangeRate":0.117064},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.141569},{"month":12,"riseRate":0.4,"avgChangeRate":0.218437}],"exchange":"NASDAQ","name":"Absci Corporation.","nameEN":"Absci Corporation."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Absci Corporation.,ABSI,Absci Corporation.股票,Absci Corporation.股票老虎,Absci Corporation.股票老虎国际,Absci Corporation.行情,Absci Corporation.股票行情,Absci Corporation.股价,Absci Corporation.股市,Absci Corporation.股票价格,Absci Corporation.股票交易,Absci Corporation.股票购买,Absci Corporation.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}